Vioxx - In The News (vioxx articles)
Vioxx information from news sources across the country and around the world.The articles listed on this page are about the drug Vioxx, the Vioxx recall, commentary from doctors and other individuals on the dangers of Vioxx.
Merck caught in scandal to bury Vioxx heart attack risks, intimidate scientists and keep pushing dangerous drugs; Vioxx lawsuits now forming
The truth has finally come out about Vioxx: insider emails published by the Wall Street Journal reveal that Merck, the maker of Vioxx, was fully aware...
April 11, 2006
"Vioxx jury: Merck lied, must pay
No. 2 drugmaker vows appeal as jury awards $9 million in punitive damages related to the painkiller.
By Aaron Smith, CNNMoney.com staff writer
NEW YORK (CNNMoney.com) - A New Jersey jury found Merck liable Tuesday of misrepresenting Vioxx to federal regulators, and ordered the drugmaker to pay $9 million in punitive damages to a man who suffered a heart attack after taking the painkiller." read more about the Vioxx Award here...
For more detailed information about filing a Vioxx Claim or Lawsuit, please fill out the form below, then read on
Article Contiunes...
Reputation of the FDA in shambles after Vioxx scandal; calls for wholesale FDA reform gain momentum
"...the agency’s senior management is more concerned with external appearance than rigorous science." -- Dr. Richard Horton, editor, The Lancet The...
History tells us that the reintroduction of Vioxx into the market may not be as easy as many believe
While the FDA approved the reintroduction of Vioxx into the marketplace, it may not occur after all. The only other drug to make such a comeback was Lotronex...
Merck now under criminal investigation by the Justice Department for Vioxx scandal
Pharmaceutical giant Merck is now under scrutiny by the Justice Department, which has begun a criminal investigation into the firm’s marketing of the painkiller...
Vioxx only the beginning; antidepressants and statin drugs are medication timebombs
There's a much bigger story than you might think about the recent hoo-ha concerning Vioxx being pulled from the market. It's not just about Vioxx or Merck...
Scientists question Merck's attempts to discredit its own report linking Vioxx to heart attacks
Two scientists who worked on a study that concluded Merck & Co's pain pill Vioxx might lead to heart attacks have raised concerns about the company's reaction...
Vioxx disaster shows health hazards of prescription drugs, failure of FDA to protect the public
There is a new national uproar over a prescription drug, Vioxx, which has been an extremely popular anti-inflammatory drug manufactured and marketed by...
FDA panel concludes that Vioxx should be available to those who benefit from the drug
The FDA concluded that despite possible heart problems, patients should have access to Vioxx and similar drugs if they can benefit from them. While the...
Growing number of lawsuits filed against Vioxx maker Merck
A growing number of people who suffered heart attacks, strokes and other health problems after they started taking the anti-inflammatory painkiller Vioxx...
Former Vioxx patients are confused because conventional medicine doesn't offer natural health options
Conventional medicine is fairly limited in its philosophy: drugs and surgery. And if one drug doesn't work (or might kill you) then the only option is...
A recent study shows that doctors overprescribed Vioxx; oversaturation of advertising may be the culprit
A recent study examined the tendencies of doctors to prescribe Vioxx, a drug that Merck recalled after learning that it increased the risk of heart attack...
Individual and class action lawsuits over Vioxx have been consolidated into one case
Merck, the maker of the drug Vioxx, is about the face off against one large, combined lawsuit that consolidates hundreds of individual and class actions...
Committee discusses side effects of Vioxx use; studies show that health problems are common even at low doses
David Graham, who became well known as the FDA whistleblower who raised questions about Vioxx last fall, spoke before the FDA committee and again voiced...
Dangers of Vioxx drug were apparent four years ago; drug should have been pulled in 2000, say Swiss researchers
And why wasn't it pulled? Only the FDA can answer that question. Maybe it has something to do with the FDA's true, unreported mission: to protect the profits...
Vioxx lawsuits beginning; class action suits may just be the start
Only days after the anti-arthritis drug Vioxx was recalled by its maker, class action lawsuits were launched across Canada against pharmaceutical giant...
With COX-2 decision, no longer any doubt about FDA corruption and U.S. drug racket
Following the death of as many as 60,000 Americans from COX-2 inhibitors (source: British Medical Journal, author Dr. David Graham, FDA drug safety researcher...
Merck now under investigation by the Securities and Exchange Commission (SEC) for possibly misleading investors
Merck, already under fire for its Vioxx scandal and now undergoing criminal investigation by the Justice Department, is now also being investigated by...
Merck rolls out spin machine to defend itself in Vioxx scandal
Following the recall of Vioxx on September 30, 2004, Merck & Co. is trying to defend itself. It has made television appearances and placed ads in seven...
Vioxx withdrawal shows weakness in approval regimen; FDA system not thorough enough
The withdrawal of Merck's mega-selling drug Vioxx came only after a failure on the part of the company, and the FDA, to adequately test the drug's impact...
New data show 139,000 heart attacks linked to Vioxx - Dr. David Graham
Thanks to new research by drug safety advocate Dr. David Graham, it turns out that as many as 139,000 people may have suffered heart attacks caused by...
FDA panel concludes Vioxx safe enough to return to market
A FDA advisory panel voted 17-15 that the arthritis painkiller Vioxx is safe enough to be prescribed to patients, as long as they are warned of the risks...
The FDA failed the American people, says senior drug safety researcher
FDA drug safety researcher Dr. David Graham told senators the U.S. is virtually defenseless against another scandal such as Vioxx. A Merck executive, in...
On Merck and Vioxx, Justice Department doing the work of the FDA says drug safety expert
When the FDA fails to perform its sole regulatory function and protect the health of the public, law enforcement gets involved. In this case, the Justice...
FDA called medical journal to block publication of Vioxx article, insider email reveals
No surprise here: it's yet more evidence that the FDA is clearly acting in the best interests of drug companies rather than trying to actually protect...
Vioxx may have caused 140,000 heart problems, government report says
A new report from the U.S. Food and Drug Administration says the painkiller Vioxx may have caused more than 140,000 cases of coronary heart disease. The...
After Vioxx recall, the FDA and Merck both claim that all other drugs are perfectly safe
"We were wrong about Vioxx, but you can trust us on all those other meds," the FDA seems to be saying.
Vioxx fiasco raises concerns about heart attack and stroke risk of other anti-inflammatory COX-2 inhibitor drugs
Ah, how quickly we forget: Vioxx was originally peddled to the public as the "safe" anti-inflammatory drug, remember? The funny part is that all those...
Arthritis pain drug Mobic found to present higher heart attack risk than banned Vioxx, says study
A new study says the arthritis drug Mobic may be even riskier than Vioxx, a pill that voluntarily withdrew last year after reports that it lead to heart...
Safety questions about Vioxx, similar drugs leave arthritis patients in a bind
Arthritis patients should be forgiven for being confused and concerned these days. Just months after taking the pain pill Vioxx off the market because...
Study indicates Vioxx doubled risk of heart attack and stroke in cancer trials
Researchers studying the effects of Vioxx as a cancer preventative treatment for patients suffering from recurrent non-cancerous colon polyps found that...
Vioxx lawsuits face uphill battle in federal court
Class-action suits seeking damages from Merck for negligence in the sale of the popular painkiller Vioxx may have a difficult road, according to legal...
Merck may put Vioxx back on the market
After a favorable vote from an FDA advisory panel, the pharmaceutical company Merck is considering putting the arthritis painkiller Vioxx back on the market...
Vioxx and Celebrex were widely overprescribed to people who did not need these drugs
The painkillers Vioxx and Celebrex, designed to be used by people at risk for gastrointestinal bleeding, were commonly prescribed for people who did not...
Doctors can learn something from Vioxx fiasco, says physician
A Vanderbilt University Medical Center associate dean says it's important for Americans to remember that all drugs have risks. That's the main lesson that...
Vioxx concerns spawn new FDA drug safety board
Health and Human Services Secretary Michael Leavitt has announced formation of the Office of Drug Safety, an independent arm of the Food and Drug Administration...
Vioxx cases might be as big as the tobacco settlements of the '90's, industry experts predict
Problems with its arthritis pain killer Vioxx will likely cost pharmaceutical giant Merck & Co. at least $24 billion industry analysts say. The company...
Tens of thousands of people suffer heart damage as a result of taking Vioxx
The U.S. Food and Drug Administration has determined that as many as 140,000 American patients may have suffered heart damage from the arthritis drug Vioxx...
Problems with Vioxx prompt Bush's call for beefed-up FDA drug-monitoring programs
In his tightly packed federal budget proposal that calls for deep cuts to many government programs, President Bush asks for a 24 percent funding increase...
FDA scientist Dr. David Graham forced to blow the whistle by FDA negligence
Dr. David Graham, a top FDA scientist, released information today that stated the FDA forced him to blow the whistle on Vioxx by neglecting to protect...
Officials debate giving FDA more power over drug labeling
The recent Vioxx scandal has started a whole new debate on the powers of the FDA. Officials are considering whether to give the FDA more authority over...
Fish oils and omega-3 fatty acids allow patients to ditch Vioxx and other anti-inflammatory drugs
Interesting new research has been conducted on the health effects of fish oils and omega-3 fatty acids as alternative replacements for anti-inflammatory...
Patients should demand full lifetime refunds on Vioxx, COX-2 inhibitors and other drugs
Let's take a closer look at honesty in medicine. Over the last few months, the FDA and state legal authorities have been going after a company selling...
Vioxx alternative equally troublesome, says FDA whistle-blower
An FDA safety officer has told a conference that a recent large-scale study shows that Mobic, an anti-inflammatory that thousands of arthritis sufferers...
Bush wants more money for FDA drug monitoring; request comes in wake of agency's Vioxx fiasco
President Bush has asked Congress to give the Food and Drug Administration $6.5 million more this year in order to improve drug monitoring programs. The...
All Cox-2 inhibitors have negative consequences, FDA researcher testifies
In a FDA committee this week, David Graham explained that he was upset over some of the actions of the FDA. He quoted studies that show that Cox-2 inhibitors...
Safety questions about Vioxx give patients reasons to try alternative treatments
As questions about the safety of well known drugs like Vioxx and Celebrex continue to make news, some people are trying alternative treatments. Practitioners...
Merck's Arcoxia painkiller may share side effects with Vioxx
Arcoxia is the successor drug to Merck's withdrawn Vioxx painkiller product, and it appears to have problems with heart conditions, according to federal...
Maker of Vioxx researching new nasal spray for obesity
Merck and Co., which pulled its arthritis painkiller Vioxx from the market late last year after it was linked to heart attacks, is a partner in a new nasal...
Drug shield law leaves Michigan residents without recourse against dangerous drugs
As liability claims come roaring in against the makers of famously problematic drugs like Vioxx and Celebrex, Michigan residents will not be part of the...
FDA announces intention to investigate itself following Vioxx scandal
With the FDA's reputation in the gutter following the recent Vioxx scandal, not to mention it's suppression of scientist warnings about antidepressant...
FDA delays approval of Merck's Arcoxia drug amid concerns of side effects resembling Vioxx
If the FDA is suddenly getting more cautious in approving prescription drugs, that's of benefit to everyone. Perhaps with all the scrutiny the agency has...
Arthritis drug Bextra found to promote heart attacks and strokes
Following the recent revelations that Vioxx cause a high incidence of heart attacks and strokes, a competing drug from Pfizer, Bextra, has now been shown...
Vioxx takes over as the leading term spammers use in email subject lines
Believe it or not, someone at AOL really tallies up the words spammers use in their email subject lines. And at last count, the word Vioxx was the most...
Drug company investors to experience accelerating losses as pharmaceutical company stock prices continue to fall
The stock prices of drug companies have been hammered over the last six months thanks to a series of scandals regarding the safety of drugs that have long...
Study reveals why COX-2 inhibitors cause heart attacks and other dangerous side effects
Every prescription drug is unsafe, the FDA recently admitted. Every drug on the market has unintended side effects, and the fallout from this is that people...
The bad news keeps coming for the painkillers
With the news that Vioxx, Celebrex, Bextra, and Aleve all cause an increase in the risk of heart disease and stroke, there doesn't seem to be any good...
Understanding drug risk: why no drug is 100% safe
There have been many news reports in past months about associations between popular pain medications such as Vioxx, Celebrex, and Aleve with heart attacks...
Columnist says FDA promises to open up, but has a long way to go
Reeling from criticism that it ignored the possible health risks associated with the popular arthritis painkiller Vioxx, the Food and Drug Administration...
FDA buys software to analyze dangerous drug side effects to heart health; but will it make the agency more honest?
This new technology is interesting, but the problem with the FDA and the Vioxx scandal wasn't that the FDA didn't know the drug was toxic to the heart...
FDA accused of bypassing clinical trial requirements on several painkillers; licenses for several popular drugs now under review
A Cleveland area doctor claims the U.S. Food and Drug Administration approved several new pain killers before proper clinical studies had been conducted...
Heavy metals warning for ayurvedic herbs is a distraction from the real threats to your health
The headlines were recently ablaze with warnings about Ayurvedic herbal products. A survey of such herbal remedies sourced from India and Pakistan found...
Whistleblower credits his religious faith with helping him take on FDA
David Graham said it was his Catholic faith that led him to blow the whistle on the Food and Drug Administration. Graham criticized the FDA for failing...
Now Merck wants to release another pain drug that it claims is even safer than Vioxx
Safer than Vioxx? Really? It wasn't too long ago that Merck was touting Vioxx itself as being the "safe" anti-inflammatory drug. Personally, when Merck...
Kaiser Permanente bars use of COX-2 painkiller Bextra
HMO Kaiser Permanente has barred the use of Bextra, a painkiller in the same cox-2 family of drugs as the withdrawn Vioxx. Kaiser cited concerns that...
Safety of all COX-2 inhibitors now seriously questioned as dangers of prescription drugs surface
With the recent withdrawal of Vioxx from the market and new worries increasing over a similar drug marketed under the name of Bextra, researchers are concerned...
Makers of embattled arthritis drugs need clear statements from experts during upcoming FDA meeting
Much is riding on the outcome of a planned Feb. 16 Food and Drug Administration meeting over the troubled drugs Celebrex, Vioxx, and Bextra. The makers...
FDA named "Fraud and Drug Administration" by consumer health advocacy group
The U.S. Food and Drug Administration, under sharp criticism for its drug safety behavior involving anti-inflammatory drugs, antidepressants, and the silencing...
FDA says painkiller Prexige poses similar risks to Vioxx
American regulators say that a clinical trial for a new painkiller, Prexige, indicates that the drug increases the risk of heart attack, strokes, or even...
Big Tobacco racketeering charges mirror pharmaceutical industry crimes
The United States Justice Department charges that under the Racketeer Influenced and Corrupt Organizations Act (RICO), cigarette companies have deceived...
Possible ban on COX-2 inhibitors may leave arthritic patients without medication
Three painkillers of a class known as COX-2 inhibitors are all under scrutiny, and one has been withdrawn from the market, after studies linked them to...
The FDA says it has done nothing wrong, no need for major changes
It's becoming increasingly clear that the FDA is going to stonewall true reform efforts just like it stonewalled negative evidence proving Vioxx and antidepressant...
FDA advisory panel allows sales of dangerous COX-2 arthritis painkillers to continue
A government advisory panel has voted to allow doctors to continue to prescribe the popular arthritis painkillers Celebrex, Bextra, and Vioxx despite lingering...
American Medical Association calls for wholesale reforms of the FDA
There's a major development unfolding in the world of conventional medicine. As you know, I've been calling for major reform of the FDA for several years...
Arthritis drug Bextra raises risk of heart attack for bypass patients, researchers say
On the heels of the Vioxx disaster, Pfizer is now under fire for dangerous side effects associated with its own arthritis drug Bextra.
Painkiller Bextra might lead to heart attack risk when combined with aspirin
New studies say that the popular painkiller Bextra, when taken with aspirin, seems to significantly increase a patient's risk of heart attack. Bextra is...
FDA defends its credibility by admitting that all prescription drugs are dangerous
Finally, we have an admission from the FDA that all prescription drugs are dangerous! At a Senate hearing, Dr. David Graham presented evidence regarding...
Bayer accused of withholding evidence, delaying Baycol cholesterol drug warnings
Bayer, the manufacturer of Baycol, a cholesterol drug that was linked to over 100 deaths and pulled from the market in 2001, may have had advance knowledge...
Prescription drug advertisements causing controversy
Ads for prescription drugs like Nexium and Vioxx are causing controversy. It has been seven years since the FDA lifted rules against such direct-to-consumer...
It's been a rough time for drug companies -- and patients
With all the bad news coming out of the pharmaceutical industry lately, it has been a rough time for anyone who is hoping to get decent medication. With...
Dr. Eric J. Topol, a prominent cardiologist, criticizes ads for prescription drugs
Though the FDA has not yet weighed in on whether prescription drug ads are in the public's best interests, Dr. Eric J. Topol of the Cleveland Clinic has...
Prescription drug advertising will get more scrutiny, FDA promises
Makers of prescription drugs can expect more scrutiny of their ads, Food and Drug Administration officials say. In the wake of highly publicized problems...
Vioxx, Celebrex downfall lead some to question direct to consumer advertising
The withdrawal of the painkiller Vioxx, and the troubles surrounding Celebrex, have some physicians questioning the value of advertising drugs directly...
Professor booted from FDA drug-safety committee restored to panel
Curt Furberg, a professor at Wake Forest University Health Sciences, was removed from an FDA committee after criticizing Pfizer for some drug-trial practices...
Cox-2 inhibitors are given the okay by FDA despite mounting evidence against them
Almost half of the FDA advisory panel voted against the sale of Cox-2 inhibitors, according to a recent radio transcript of an interview. Growing research...
Swing votes on COX-2 panel had ties to painkiller industry
A government panel of drug advisers last week recommended that the painkillers Celebrex, Bextra and Vioxx should continue to be marketed. It has now been...
FDA plans stricter approach to ad approval
In the wake of the scandals surrounding Celebrex and Vioxx, the FDA has announced plans to step up its oversight of drug advertising aimed at consumers...
FDA plans tougher scrutiny, oversight of consumer-oriented drug ads
The Food and Drug Administration says that it will exercise tougher oversight of drug advertisements aimed at consumers, citing the disastrous history...
The FDA reminds people that they shouldn't overdo it on painkillers
The FDA has issued a statement that people should not take over-the-counter painkillers for longer than ten days. With new studies showing that the painkillers...
